Frost & Sullivan, Feb 2008, Pages: 138
... procurement, distribution, policy, safety and epidemiology as these topics are applied to preventive vaccines, therapeutic vaccines, infectious disease ...
John Wiley and Sons Ltd, Nov 2007, Pages: 264
... Analysis of current treatment and key therapeutic strategies, including surgery, immunotherapy, vaccines and combination therapies. ...
La Merie, Sep 2009, Pages: 36
... inhibitors. Specific therapeutic vaccines and antibodies are included in those novel targeted HCV treatment modalities. Other novel ...
Decision Resources, Inc., July 2007, Pages: 28
... and broader disease coverage. Another emerging trend is that of therapeutic vaccines. Vaccine manufacturers are ploughing significant ...
Spectra Intelligence, April 2006, Pages: 369
...vaccines 5.10 Rational design: bioinformatics and proteomics 5.11 Other interesting areas for vaccine development 5.12 Conclusion 6 Therapeutic antibodies and ...
Bioseeker, Sep 2005, Pages: 179
... Other approaches include the development of therapeutic vaccines to specifically stimulate the immune system against Her2 positive cancer cells. ...
CYGNUS Business Consulting & Research, Jan 2008, Pages: 211
... Immunology The Cancer Vaccine Concept Preventive Cancer Vaccines Merck?s Gardasil GlaxoSmithKline?s Cervarix Therapeutic Cancer Vaccines Cancer Vaccine...
Business Insights, Jan 2005 ... Tumour Vaccines Viral Vectors and DNA Vaccines Idiotype Vaccines Dendritophages Molecular Targets of Therapeutic Vaccines Therapeutic Vaccines in Clinical ...
Research In China, Aug 2009, Pages: 77
... idiotype Monoclonal Antibodies 10.8.4 DNA and Virally Encoded Vaccines 10.8.5 ... Efficacy in preclinical models Box 2: Anti-angiogenesis: Therapeutic strategies. ...
Research In China, Aug 2009, Pages: 77
... The total Biopharma industry, comprising of vaccines, therapeutics, other products like statins, and diagnostics registered 26.9% growth in 2006-07 and the ...
Bioseeker, Jan 2007, Pages: 750
... strategies of cancer immunotherapy aim at exploiting the therapeutic potential of tumor-specific antibodies and cellular immune effector mechanisms (vaccines). ...
Datamonitor, April 2005, Pages: 237
... strategies of cancer immunotherapy aim at exploiting the therapeutic potential of tumor-specific antibodies and cellular immune effector mechanisms (vaccines). ...
Drug and Market Development Publishing, Jan 2006, Pages: 166
... Gambro Joins Forces with the Walter Reed Army Institute of Research II-33 Gambro Collaborates with Dendreon for Commercialization of Therapeutic Vaccines II-34 ...
Global Industry Analysts, Inc., July 2009, Pages: 842
... 87 KEY THERAPY STRATEGIES 871 Therapeutic Type, Targets & Mechanisms 88 CURRENT DRUG DEVELOPMENT: THE EARLY STAGE PIPELINE 881 Vaccines: Active Immunotherapy a ...
Arrowhead Publishers, Dec 2005, Pages: 261
... IFN alfa but only targets patients relapsing from, or intolerant to, previous IFN-based therapy 79 Profile 79 Analysis 81 Therapeutic HCV vaccines have been ...
